Clinical Neuroimaging

Clinical neuroimaging is a multidisciplinary field that encompasses the use of various imaging techniques to visualize the structure and function of the brain in health and disease. Neuroimaging methods provide valuable information about brain anatomy, physiology, connectivity, and metabolism, allowing clinicians and researchers to investigate the underlying mechanisms of neurological and psychiatric disorders, diagnose conditions, monitor disease progression, and evaluate treatment response. Common neuroimaging modalities include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), single-photon emission computed tomography (SPECT), functional MRI (fMRI), diffusion tensor imaging (DTI), magnetic resonance spectroscopy (MRS), and electroencephalography (EEG). Each imaging technique has its unique strengths and limitations and can be used to visualize different aspects of brain structure and function. For example, MRI and CT scans provide detailed images of brain anatomy and can detect abnormalities such as tumors, strokes, hemorrhages, and traumatic injuries. PET and SPECT scans use radioactive tracers to measure brain metabolism, neurotransmitter activity, and receptor binding, offering insights into the underlying neurochemical processes in neurological and psychiatric disorders. fMRI and DTI allow researchers to study brain function and connectivity by measuring changes in blood flow and white matter tracts, respectively, during cognitive tasks and resting state conditions. EEG records the electrical activity of the brain and is used to diagnose and monitor seizure disorders, sleep disorders, and other neurological conditions. By integrating information from multiple neuroimaging modalities, clinicians and researchers can obtain a comprehensive understanding of brain structure, function, and dysfunction, leading to improved patient care, novel discoveries, and advances in neuroscience.